Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Cash & Equivalents (2016 - 2025)

Proto Labs' Cash & Equivalents history spans 15 years, with the latest figure at $110.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 24.42% year-over-year to $110.8 million; the TTM value through Dec 2025 reached $110.8 million, up 24.42%, while the annual FY2025 figure was $110.8 million, 24.42% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $110.8 million at Proto Labs, up from $104.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $110.8 million in Q4 2025 and bottomed at $41.9 million in Q2 2021.
  • The 5-year median for Cash & Equivalents is $74.6 million (2023), against an average of $73.9 million.
  • The largest annual shift saw Cash & Equivalents crashed 59.58% in 2021 before it skyrocketed 49.56% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $65.9 million in 2021, then dropped by 14.21% to $56.6 million in 2022, then surged by 48.15% to $83.8 million in 2023, then increased by 6.3% to $89.1 million in 2024, then increased by 24.42% to $110.8 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's Cash & Equivalents are $110.8 million (Q4 2025), $104.4 million (Q3 2025), and $90.4 million (Q2 2025).